Concert Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Concert Pharmaceuticals patents 32 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS OF TREATMENT WITH DEUTERATED ANALOGS OF D-SERINE Filling date: 26 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS Filling date: 26 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE Filling date: 26 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: 4-HYDROXYBUTYRIC ACID ANALOGS Filling date: 26 Sep 2025 Issue date: 26 May 2022 |
Grant | Utility: Deuterated EPI-743 Filling date: 26 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY Filling date: 26 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: 4-HYDROXYBUTYRIC ACID ANALOGS Filling date: 26 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: NOVEL DEUTERATED JAK INHIBITOR AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: Morphinan Compounds Filling date: 26 Sep 2025 Issue date: 11 Nov 2021 |
Grant | Utility: 4-hydroxybutyric acid analogs Filling date: 26 Sep 2025 Issue date: 2 Nov 2021 |
Application | Utility: DEUTERATED DERIVATIVES OF RUXOLITINIB Filling date: 26 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: DEUTERATED EPI-743 Filling date: 26 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: DEUTERATED ANALOGS OF D-BETA-HYDROXYBUTYRIC ACID AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: DEUTERATED ANALOGS OF D-SERINE AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: 4-HYDROXYBUTYRIC ACID ANALOGS Filling date: 26 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: DEUTERATED ANALOGS OF D-SERINE AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 26 Nov 2020 |
Grant | Utility: Deuterated idebenone Filling date: 26 Sep 2025 Issue date: 24 Nov 2020 |
Grant | Utility: Deuterated baricitinib Filling date: 26 Sep 2025 Issue date: 24 Nov 2020 |
Grant | Utility: Morphinan compounds Filling date: 26 Sep 2025 Issue date: 27 Oct 2020 |
Application | Utility: TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS Filling date: 26 Sep 2025 Issue date: 16 Jul 2020 |
Grant | Utility: Deuterated OTX-015 Filling date: 26 Sep 2025 Issue date: 16 Jun 2020 |
Grant | Utility: Deuterated analogs of D-serine and uses thereof Filling date: 26 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Treatment of hair loss disorders with deuterated JAK inhibitors Filling date: 26 Sep 2025 Issue date: 18 Feb 2020 |
Application | Utility: MORPHINAN COMPOUNDS Filling date: 26 Sep 2025 Issue date: 23 Jan 2020 |
Grant | Utility: 4-hydroxybutyric acid analogs Filling date: 26 Sep 2025 Issue date: 14 Jan 2020 |
Application | Utility: DEUTERATED IDEBENONE Filling date: 26 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: DEUTERATED MORPHINAN COMPOUNDS FOR TREATING AGITATION Filling date: 26 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: DEUTERATED ANALOGS OF D-SERINE AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 31 Oct 2019 |
Grant | Utility: Deuterated GFT-505 Filling date: 26 Sep 2025 Issue date: 15 Oct 2019 |
Application | Utility: DEUTERATED DERIVATIVES OF RUXOLITINIB Filling date: 26 Sep 2025 Issue date: 10 Oct 2019 |
Grant | Utility: Morphinan compounds Filling date: 26 Sep 2025 Issue date: 10 Sep 2019 |
Grant | Utility: Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase Filling date: 26 Sep 2025 Issue date: 20 Aug 2019 |
Showing 1 to 32 of 32 patents.